237 related articles for article (PubMed ID: 34128238)
1. Insights into the mechanisms underlying opioid use disorder and potential treatment strategies.
Cao DN; Li F; Wu N; Li J
Br J Pharmacol; 2023 Apr; 180(7):862-878. PubMed ID: 34128238
[TBL] [Abstract][Full Text] [Related]
2. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
[TBL] [Abstract][Full Text] [Related]
3. Maintenance medication for opiate addiction: the foundation of recovery.
Bart G
J Addict Dis; 2012; 31(3):207-25. PubMed ID: 22873183
[TBL] [Abstract][Full Text] [Related]
4. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Jordan CJ; Cao J; Newman AH; Xi ZX
Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
[TBL] [Abstract][Full Text] [Related]
5. Opioid research in the time of the opioid crisis.
Traynor JR; Moron JA
Br J Pharmacol; 2023 Apr; 180(7):793-796. PubMed ID: 36813266
[TBL] [Abstract][Full Text] [Related]
6. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
7. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Chalhoub RM; Kalivas PW
Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
[TBL] [Abstract][Full Text] [Related]
8. Strategies towards safer opioid analgesics-A review of old and upcoming targets.
Varga BR; Streicher JM; Majumdar S
Br J Pharmacol; 2023 Apr; 180(7):975-993. PubMed ID: 34826881
[TBL] [Abstract][Full Text] [Related]
9. Medications for management of opioid use disorder.
Koehl JL; Zimmerman DE; Bridgeman PJ
Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive memantine for opioid use disorder treatment: A systematic review.
Elias AM; Pepin MJ; Brown JN
J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
[TBL] [Abstract][Full Text] [Related]
11. CE: Acute Pain Management for People with Opioid Use Disorder.
Broglio K; Matzo M
Am J Nurs; 2018 Oct; 118(10):30-38. PubMed ID: 30211703
[TBL] [Abstract][Full Text] [Related]
12. Medications for Treatment of Opioid Use Disorder among Persons Living with HIV.
Fanucchi L; Springer SA; Korthuis PT
Curr HIV/AIDS Rep; 2019 Feb; 16(1):1-6. PubMed ID: 30684117
[TBL] [Abstract][Full Text] [Related]
13. Update on pharmacotherapy for treatment of opioid use disorder.
Ayanga D; Shorter D; Kosten TR
Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
[TBL] [Abstract][Full Text] [Related]
14. Update on Barriers to Pharmacotherapy for Opioid Use Disorders.
Sharma A; Kelly SM; Mitchell SG; Gryczynski J; O'Grady KE; Schwartz RP
Curr Psychiatry Rep; 2017 Jun; 19(6):35. PubMed ID: 28526967
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine initiation to treat opioid use disorder in emergency rooms.
Jaeger S; Fuehrlein B
J Neurol Sci; 2020 Apr; 411():116716. PubMed ID: 32097813
[TBL] [Abstract][Full Text] [Related]
16. Overview of Drugs Used to Treat Opioid Use Disorder.
Aschenbrenner DS
Am J Nurs; 2018 Aug; 118(8):25. PubMed ID: 30048283
[No Abstract] [Full Text] [Related]
17. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
Shulman M; Weiss R; Rotrosen J; Novo P; Costello E; Nunes EV
Addict Sci Clin Pract; 2021 Mar; 16(1):15. PubMed ID: 33676577
[TBL] [Abstract][Full Text] [Related]
18. Help Is on the Way: Medicare Coverage of Opioid Treatment Programs.
Felix C; Sharfstein JM; Olsen Y
J Am Geriatr Soc; 2020 Mar; 68(3):637-640. PubMed ID: 31825528
[TBL] [Abstract][Full Text] [Related]
19. Emerging areas of opioid pharmacology.
Kelly E; Henderson G; Bailey CP
Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
[TBL] [Abstract][Full Text] [Related]
20. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.
Camenga DR; Colon-Rivera HA; Muvvala SB
J Stud Alcohol Drugs; 2019 Jul; 80(4):393-402. PubMed ID: 31495374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]